Sobi - Swedish Orphan Biovitrum AB (publ) · 3 days ago
Corporate Recruiter - One Year Contract
Sobi is a specialized biopharmaceutical company dedicated to improving the lives of people with rare diseases. They are seeking a Corporate Recruiter with strong pharma experience to lead end-to-end hiring across North America, partnering with hiring managers and designing sourcing strategies for critical talent markets.
BiotechnologyGeneticsMedicalPharmaceutical
Responsibilities
Own full-cycle recruiting for assigned requisitions (intake, sourcing, offers, and handover to onboarding), meeting agreed SLAs and quality standards
Act as a trusted advisor to hiring managers: challenge profiles constructively, calibrate markets, and shape assessment processes for speed and quality
Drive direct sourcing across North America (LinkedIn Recruiter, talent mapping, referrals, communities, niche job boards)
Manage pipelines for critical pharma profiles (with focus on Medical Affairs and Commercial) with an eye on rare-disease talent
Coordinate interviews; brief/debrief stakeholders; maintain momentum and candidate engagement
Partner with HR to ensure smooth transitions to onboarding
Track and report recruiting metrics (time-to-fill, pipeline health, candidate experience, diversity slates) and recommend data-driven improvements
Qualification
Required
5+ years of full-cycle recruiting experience, with at least 3 years in the pharmaceutical/biotech in North America
Proven success hiring for pharma roles in Commercial and/or Medical
Deep knowledge of the North American talent market and with networks in commercial and/or medical within the region; strong stakeholder management with senior leaders
Proficiency with ATS and sourcing tools (e.g., SmartRecruiters, LinkedIn Recruiter); disciplined pipeline and data management
Strong assessment capability and structured interviewing; familiarity with competency- and values-based approaches
High integrity and discretion with candidate data
Comfortable working in a fast-paced environment with multiple priorities and short timelines
Company
Sobi - Swedish Orphan Biovitrum AB (publ)
Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases.
Funding
Current Stage
Public CompanyTotal Funding
$825.99M2024-05-08Post Ipo Debt· $274.92M
2023-08-22Post Ipo Equity· $551.07M
2006-09-15IPO
Leadership Team
Guido Oelkers
Chief Executive Officer
Recent News
Pharma Letter
2026-02-06
Morningstar.com
2026-02-05
News Powered by Cision
2026-02-03
Company data provided by crunchbase